Managed Care and Risk-Bearing Organizations

Build a measurable pathway to reduce preventable adverse and high-cost events.

NS1 helps managed-care and risk-bearing organizations recognize priority risk across populations, model the addressable opportunity, design a bounded pilot, and measure whether the pathway supports better clinical action and lower avoidable cost.

Programs can begin with qualified aggregate information and current organizational workflows where feasible. NS1 connects the population question, baseline, pilot design, measurement plan, and commercial pathway while the organization retains its clinical, data, privacy, security, and approval authority.

Protective hands surround diverse families, caregivers, clinicians, older adults, children, and people using mobility aids within a connected care network.

No upfront NS1 pilot feeEasy implementationPerformance based

The NS1 managed-care solution

One pathway from a population question to a measurable program.

NS1 keeps the executive story simple while protecting the underlying model, technology configuration, thresholds, pricing, and customer-specific assumptions.

01

Recognize priority risk

Define the preventable adverse or high-cost event, population question, current baseline, financial risk holder, and evidence required to proceed.

02

Model the addressable opportunity

Use qualified aggregate inputs to estimate the addressable population, compare scenarios, and identify the assumptions that materially affect the decision.

03

Design the bounded pilot

Establish the smallest responsible cohort, workflow, clinical ownership, measures, responsibilities, and decision gates before activation.

04

Measure execution and outcomes

Track data readiness, risk recognition, clinical validation, care-pathway action, adverse events, and economic results as distinct evidence stages.

05

Align economics with performance

Connect scale and payment to contract-defined, validated outcomes with agreed baseline, attribution, observation, validation, audit, and payment rules.

Three executive advantages

Begin responsibly. Implement practically. Align economics with results.

The program is designed to make the first decision easier without giving up the evidence, governance, or measurement required for a responsible scale decision.

01

No upfront NS1 pilot fee

Qualified organizations can begin with a defined no-charge pilot under an agreed scope and terms.

02

Designed for easy implementation

Start with information and workflows the organization already has where feasible, using a bounded scope, named owners, and clear decision gates.

03

Performance-based pathway

Align scale and economics to mutually agreed measures and validated outcomes—not modeled opportunity alone.

A no-charge pilot refers only to NS1’s fee for the agreed pilot scope. Organization-specific data, integration, clinical, treatment, and operating costs are determined during qualification. Technical and workflow fit are confirmed before activation.

Illustrative real-world use case

From a preventable adverse event to a measurable intervention pathway.

Consider a risk-bearing organization seeking to reduce the incidence and cost of a selected preventable adverse or high-cost event across a defined population. NS1 begins with qualified aggregate information and current workflows to establish the baseline, identify the priority population, and define where clinical and economic value may be tested.

NS1 then models the addressable opportunity, identifies the smallest clinically responsible pilot cohort, and establishes the workflow, accountable owners, measures, and decision gates required to test the pathway before broader implementation.

This is an illustrative planning use case—not a named customer deployment, diagnosis, guaranteed reduction, observed outcome, or savings claim. Eligibility, baseline events, attribution, costs, clinical action, and results require organization-specific validation.

Population questionWhere is preventable risk concentrated?
Available evidenceWhich aggregate clinical, claims, and operational information can be qualified?
Pilot designWhat is the smallest responsible cohort, baseline, and workflow?
Executive decisionDo validated results support modifying, scaling, or stopping?

Customized opportunity modeling

See the range, the operating reality, and the evidence still required.

NS1 can compare qualified operating, broader-context, and sensitivity scenarios without disclosing proprietary calculations or representing modeled value as performance.

PRIMARY

Qualified Operating Scenario

Most decision-useful view

Uses validated inputs and explicit implementation requirements to frame the practical opportunity.

Modeled · Qualified
CONTEXT

Broader Opportunity Scenario

Full planning context

Tests what may be addressable if broader assumptions are later supported.

Modeled · Contextual
SENSITIVITY

Assumption Stress Test

Decision resilience

Shows how the planning conclusion changes when the most important assumptions move.

Modeled · Not observed

Organization-specific values depend on validated population, data, clinical assumptions, implementation, costs, risk ownership, and program execution. Detailed methods, formulas, thresholds, commercial terms, and customer-specific assumptions remain confidential.

Pilot planning and ease of implementation

Start with the smallest responsible test.

A bounded readiness and pilot pathway can use qualified aggregate information and existing data or care workflows where feasible, reducing disruption while preserving clinical, privacy, security, and operating controls.

Existing-data and minimal-disruption design are objectives, not guarantees. Technical fit, data rights, clinical ownership, security, integration, treatment, and implementation requirements vary by organization.

01

Qualify — define the business question, population, accountable owners, and baseline.

02

Design — confirm data, workflow, privacy, measures, and the smallest useful scope.

03

Validate — test the bounded pathway and separate operational signals from long-term outcomes.

04

Decide — pilot, modify, scale, extend validation, or stop based on the evidence.

Performance-based pathway

Align scale and economics with validated performance.

A performance-based program can connect agreed economics to contract-defined, validated outcomes—such as an agreed reduction in preventable adverse or high-cost events—after the parties establish the baseline, attribution, observation period, validation ownership, audit method, and payment terms.

The pathway may begin with a defined no-charge pilot, a qualified analysis, a performance-based structure, or a controlled hybrid. Modeled opportunity guides the decision and pilot design; only validated results can support performance economics.

Discuss a Performance-Based Program
01

Agree on the question and value recipient.

02

Define the baseline and measurable evidence.

03

Separate modeled opportunity from validated results.

04

Align scale and economics with the approved outcome.

Separate clinician-directed pathway

Explore NS1’s separate baseline-to-follow-up pathway for hospital trauma centers, qualified clinical programs, insurers, workers’ compensation providers, and personal-injury care providers.

Explore Cognitive Function

Planning intelligence—not diagnosis or guaranteed performance.

NS1’s managed-care pathway supports program planning and measurement. It does not replace clinical judgment, determine member eligibility, diagnose a condition, promise an outcome, or present modeled value as realized savings.